Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Baxter
Express Scripts
McKinsey
Mallinckrodt

Last Updated: May 27, 2022

Drug Sales Trends for LOSARTAN POT


✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for LOSARTAN POT (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $129,586,946
INSIDE ANOTHER STORE $391,947,856
[disabled in preview] $1,106,917,819
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 4,803,180
INSIDE ANOTHER STORE 14,514,605
[disabled in preview] 30,919,155
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $132,778,205
MEDICARE $645,395,188
[disabled in preview] $852,322,621
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for LOSARTAN POT
Drug Units Sold Trends for LOSARTAN POT

Annual Sales Revenues and Units Sold for LOSARTAN POT

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2019
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2018
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2017
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2016
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2015
LOSARTAN POT See Plans and Pricing See Plans and Pricing 2014
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Mallinckrodt
Moodys
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.